Valuation: Integer Holdings

Market Cap 4.32B 3.92B 3.62B 3.27B 6.17B 403B 6.4B 43.62B 17.25B 218B 16.2B 15.85B 688B P/E 2026 *
55.6x
P/E 2027 * 27.4x
Enterprise Value 4.32B 3.92B 3.62B 3.27B 6.17B 403B 6.4B 43.62B 17.25B 218B 16.2B 15.85B 688B EV / Sales 2026 *
2.38x
EV / Sales 2027 * 2.25x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
1 day+0.21%
1 week+0.28%
Current month+0.30%
1 month+0.21%
3 months+1.51%
6 months+44.02%
Current year+61.89%
1 week 126.38
Extreme 126.385
133.06
1 month 126.38
Extreme 126.385
133.06
Current year 76.21
Extreme 76.21
133.06
1 year 66.51
Extreme 66.51
133.06
3 years 62
Extreme 62
146.36
5 years 50.05
Extreme 50.05
146.36
10 years 26.5
Extreme 26.5
146.36
Manager TitleAgeSince
Chief Executive Officer 56 24/10/2025
Director of Finance/CFO 53 08/05/2023
Chief Tech/Sci/R&D Officer - 01/01/2019
Director TitleAgeSince
Director/Board Member 67 02/07/2015
Director/Board Member 68 02/07/2015
Chairman 72 20/05/2026
Date Insider Type Main position Quantity % Market Cap. Importance
24/10/26 Exercice

Chief Executive Officer

6,018 0.0177%
5/10/26
Kohlberg Kravis Roberts & Co. LP
OtherCompany 5,590,069 16.4076%
5/10/26
Kohlberg Kravis Roberts & Co. LP
OtherCompany 5,590,069 16.4076%

Financials

2026 *2027 *
Net sales 1.81B 1.65B 1.52B 1.37B 2.59B 169B 2.69B 18.31B 7.24B 91.37B 6.8B 6.66B 289B 1.92B 1.74B 1.61B 1.45B 2.74B 179B 2.85B 19.41B 7.68B 96.84B 7.21B 7.05B 306B
Net income 78.66M 71.41M 65.96M 59.51M 112M 7.35B 117M 795M 314M 3.97B 295M 289M 12.53B 152M 138M 127M 115M 217M 14.2B 225M 1.54B 608M 7.67B 570M 558M 24.22B
Net Debt - -
Projected Income Statement - Annual - Integer Holdings
Logo Integer Holdings
Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.
Employees
11,000
Sector
-
Date Price Change Volume
16/11/26 US$126.97 +0.21% 798,710
13/11/26 US$126.70 +0.22% 966,699
12/11/26 US$126.42 -0.21% 393,295
11/11/26 US$126.68 +0.05% 313,568
10/11/26 US$126.62 +0.05% 673,101
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Integer Holdings
  1. Stock Market
  2. Stocks
  3. ITGR Stock